Related Experiment Video
Updated: May 29, 2026
06:47
Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
Published on: September 20, 2011
Improved tumor targeting of polymer-based nanovesicles using polymer-lipid blends
Zhiliang Cheng1, Drew R Elias, Neha P Kamat
1Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Bioconjugate Chemistry
|September 9, 2011
Summary
Polymer-lipid hybrid nanovesicles show improved cancer cell targeting compared to block copolymer-only versions. This advancement enhances nanoplatform efficacy for drug delivery and molecular imaging applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Block copolymer-based vesicles are promising nanoplatforms for targeted delivery and molecular imaging.
- Current nanovesicles utilize enhanced permeability and retention or active targeting for disease site localization.
- Improving the targeting efficacy of nanovesicles is crucial for advanced therapeutic applications.
Purpose of the Study:
- To investigate the enhanced targeting efficacy of polymer-lipid hybrid nanovesicles compared to block copolymer-only nanovesicles.
- To develop and characterize polymer-lipid hybrid nanovesicles for targeted cancer cell delivery.
- To evaluate the in vitro and in vivo performance of these hybrid nanovesicles.
Main Methods:
- Synthesized polymer-lipid hybrid nanovesicles via coassembly of poly(ethylene oxide)-block-polybutadiene (PEO-PBD) and hydrogenated soy phosphatidylcholine (HSPC).
- Functionalized PEG-based vesicles (117 nm diameter) with folic acid or anti-HER2/neu affibodies as targeting ligands.
- Assessed nanovesicle cell binding in vitro and tumor targeting in murine models.
Main Results:
- Polymer-lipid hybrid nanovesicles demonstrated significantly improved cell binding compared to block copolymer-only nanovesicles.
- Targeting ligands (folic acid, anti-HER2/neu affibodies) conferred specificity for cancer cells.
- In vitro and in vivo studies confirmed the superior targeting performance of the hybrid nanovesicles.
Conclusions:
- Nanovesicles formulated from polymer-lipid blends offer superior targeting efficacy for cancer cells.
- These hybrid nanovesicles represent a preferred embodiment for advanced drug delivery and molecular imaging.
- The findings pave the way for more effective targeted therapies using nanoplatforms.
More Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.